nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—NR3C1—type 2 diabetes mellitus	0.278	0.633	CbGaD
Ciclesonide—CYP3A4—type 2 diabetes mellitus	0.161	0.367	CbGaD
Ciclesonide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0334	0.101	CbGbCtD
Ciclesonide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0329	0.0998	CbGbCtD
Ciclesonide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0308	0.0934	CbGbCtD
Ciclesonide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0294	0.089	CbGbCtD
Ciclesonide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0268	0.0814	CbGbCtD
Ciclesonide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0253	0.0767	CbGbCtD
Ciclesonide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0242	0.0735	CbGbCtD
Ciclesonide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0235	0.0711	CbGbCtD
Ciclesonide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0212	0.0643	CbGbCtD
Ciclesonide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0161	0.0488	CbGbCtD
Ciclesonide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0154	0.0467	CbGbCtD
Ciclesonide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0154	0.0467	CbGbCtD
Ciclesonide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0146	0.0442	CbGbCtD
Ciclesonide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0109	0.0329	CbGbCtD
Ciclesonide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00994	0.0301	CbGbCtD
Ciclesonide—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00091	0.171	CrCbGaD
Ciclesonide—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000272	0.0511	CrCbGaD
Ciclesonide—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000258	0.00153	CcSEcCtD
Ciclesonide—Weight increased—Irbesartan—type 2 diabetes mellitus	0.000257	0.00152	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000257	0.00152	CcSEcCtD
Ciclesonide—Desonide—NR3C1—type 2 diabetes mellitus	0.000257	0.0483	CrCbGaD
Ciclesonide—Bronchitis—Losartan—type 2 diabetes mellitus	0.000256	0.00151	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000254	0.00151	CcSEcCtD
Ciclesonide—Angioedema—Glyburide—type 2 diabetes mellitus	0.000254	0.0015	CcSEcCtD
Ciclesonide—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000253	0.0015	CcSEcCtD
Ciclesonide—Nausea—Acarbose—type 2 diabetes mellitus	0.000253	0.0015	CcSEcCtD
Ciclesonide—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000253	0.0015	CcSEcCtD
Ciclesonide—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000252	0.00149	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00025	0.00148	CcSEcCtD
Ciclesonide—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000248	0.0466	CrCbGaD
Ciclesonide—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000247	0.00146	CcSEcCtD
Ciclesonide—Infection—Bromocriptine—type 2 diabetes mellitus	0.000246	0.00146	CcSEcCtD
Ciclesonide—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000245	0.00145	CcSEcCtD
Ciclesonide—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000245	0.00145	CcSEcCtD
Ciclesonide—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000245	0.00145	CcSEcCtD
Ciclesonide—Nausea—Nateglinide—type 2 diabetes mellitus	0.000244	0.00145	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000244	0.00144	CcSEcCtD
Ciclesonide—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000243	0.00144	CcSEcCtD
Ciclesonide—Weight increased—Losartan—type 2 diabetes mellitus	0.000242	0.00143	CcSEcCtD
Ciclesonide—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000242	0.00143	CcSEcCtD
Ciclesonide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000241	0.00143	CcSEcCtD
Ciclesonide—Back pain—Gliclazide—type 2 diabetes mellitus	0.000241	0.00143	CcSEcCtD
Ciclesonide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00143	CcSEcCtD
Ciclesonide—Rhinitis—Metformin—type 2 diabetes mellitus	0.00024	0.00142	CcSEcCtD
Ciclesonide—Pneumonia—Losartan—type 2 diabetes mellitus	0.000238	0.00141	CcSEcCtD
Ciclesonide—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000238	0.00141	CcSEcCtD
Ciclesonide—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000238	0.00141	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000237	0.0014	CcSEcCtD
Ciclesonide—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000237	0.0014	CcSEcCtD
Ciclesonide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000237	0.0014	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000236	0.0014	CcSEcCtD
Ciclesonide—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000236	0.0014	CcSEcCtD
Ciclesonide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000236	0.0014	CcSEcCtD
Ciclesonide—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000235	0.00139	CcSEcCtD
Ciclesonide—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000234	0.00139	CcSEcCtD
Ciclesonide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000234	0.00139	CcSEcCtD
Ciclesonide—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.00023	0.00136	CcSEcCtD
Ciclesonide—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.00023	0.00136	CcSEcCtD
Ciclesonide—Influenza—Ramipril—type 2 diabetes mellitus	0.000228	0.00135	CcSEcCtD
Ciclesonide—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000228	0.00135	CcSEcCtD
Ciclesonide—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000227	0.00134	CcSEcCtD
Ciclesonide—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Rash—Repaglinide—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000224	0.00133	CcSEcCtD
Ciclesonide—Epistaxis—Losartan—type 2 diabetes mellitus	0.000224	0.00132	CcSEcCtD
Ciclesonide—Headache—Repaglinide—type 2 diabetes mellitus	0.000223	0.00132	CcSEcCtD
Ciclesonide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000222	0.00132	CcSEcCtD
Ciclesonide—Sinusitis—Losartan—type 2 diabetes mellitus	0.000222	0.00132	CcSEcCtD
Ciclesonide—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000222	0.00131	CcSEcCtD
Ciclesonide—Back pain—Valsartan—type 2 diabetes mellitus	0.000222	0.00131	CcSEcCtD
Ciclesonide—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00131	CcSEcCtD
Ciclesonide—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00022	0.0013	CcSEcCtD
Ciclesonide—Flurandrenolide—NR3C1—type 2 diabetes mellitus	0.000219	0.0413	CrCbGaD
Ciclesonide—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000219	0.0013	CcSEcCtD
Ciclesonide—Back pain—Orlistat—type 2 diabetes mellitus	0.000219	0.0013	CcSEcCtD
Ciclesonide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Ciclesonide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Ciclesonide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Ciclesonide—Cough—Gliclazide—type 2 diabetes mellitus	0.000218	0.00129	CcSEcCtD
Ciclesonide—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000216	0.00128	CcSEcCtD
Ciclesonide—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000216	0.00128	CcSEcCtD
Ciclesonide—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000215	0.00127	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00127	CcSEcCtD
Ciclesonide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00127	CcSEcCtD
Ciclesonide—Rhinitis—Losartan—type 2 diabetes mellitus	0.000213	0.00126	CcSEcCtD
Ciclesonide—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000212	0.00126	CcSEcCtD
Ciclesonide—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000212	0.00126	CcSEcCtD
Ciclesonide—Hydrocortamate—NR3C1—type 2 diabetes mellitus	0.000212	0.0399	CrCbGaD
Ciclesonide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.00126	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000212	0.00125	CcSEcCtD
Ciclesonide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000212	0.00125	CcSEcCtD
Ciclesonide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000211	0.00125	CcSEcCtD
Ciclesonide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000211	0.00125	CcSEcCtD
Ciclesonide—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000211	0.00125	CcSEcCtD
Ciclesonide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000211	0.00125	CcSEcCtD
Ciclesonide—Angioedema—Valsartan—type 2 diabetes mellitus	0.000209	0.00124	CcSEcCtD
Ciclesonide—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000208	0.00123	CcSEcCtD
Ciclesonide—Weight increased—Ramipril—type 2 diabetes mellitus	0.000207	0.00123	CcSEcCtD
Ciclesonide—Angioedema—Orlistat—type 2 diabetes mellitus	0.000207	0.00122	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000206	0.00122	CcSEcCtD
Ciclesonide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000204	0.00121	CcSEcCtD
Ciclesonide—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000204	0.00121	CcSEcCtD
Ciclesonide—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000204	0.00121	CcSEcCtD
Ciclesonide—Palpitations—Valsartan—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Ciclesonide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Ciclesonide—Infection—Gliclazide—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Ciclesonide—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000202	0.0012	CcSEcCtD
Ciclesonide—Palpitations—Orlistat—type 2 diabetes mellitus	0.0002	0.00118	CcSEcCtD
Ciclesonide—Cough—Valsartan—type 2 diabetes mellitus	0.0002	0.00118	CcSEcCtD
Ciclesonide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.0002	0.00118	CcSEcCtD
Ciclesonide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000199	0.00118	CcSEcCtD
Ciclesonide—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000198	0.00117	CcSEcCtD
Ciclesonide—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000198	0.00117	CcSEcCtD
Ciclesonide—Cough—Orlistat—type 2 diabetes mellitus	0.000198	0.00117	CcSEcCtD
Ciclesonide—Budesonide—NR3C1—type 2 diabetes mellitus	0.000197	0.0371	CrCbGaD
Ciclesonide—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000197	0.0371	CrCbGaD
Ciclesonide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000197	0.00117	CcSEcCtD
Ciclesonide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000197	0.00117	CcSEcCtD
Ciclesonide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00116	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000196	0.00116	CcSEcCtD
Ciclesonide—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000195	0.00115	CcSEcCtD
Ciclesonide—Chest pain—Valsartan—type 2 diabetes mellitus	0.000195	0.00115	CcSEcCtD
Ciclesonide—Dizziness—Glipizide—type 2 diabetes mellitus	0.000195	0.00115	CcSEcCtD
Ciclesonide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000193	0.00114	CcSEcCtD
Ciclesonide—Chest pain—Orlistat—type 2 diabetes mellitus	0.000193	0.00114	CcSEcCtD
Ciclesonide—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000192	0.00114	CcSEcCtD
Ciclesonide—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000191	0.00113	CcSEcCtD
Ciclesonide—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000191	0.00113	CcSEcCtD
Ciclesonide—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000188	0.00112	CcSEcCtD
Ciclesonide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000187	0.0011	CcSEcCtD
Ciclesonide—Infection—Valsartan—type 2 diabetes mellitus	0.000186	0.0011	CcSEcCtD
Ciclesonide—Rash—Glipizide—type 2 diabetes mellitus	0.000186	0.0011	CcSEcCtD
Ciclesonide—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000186	0.0349	CrCbGaD
Ciclesonide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000185	0.0011	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000185	0.0011	CcSEcCtD
Ciclesonide—Headache—Glipizide—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Ciclesonide—Palpitations—Metformin—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Ciclesonide—Infection—Orlistat—type 2 diabetes mellitus	0.000184	0.00109	CcSEcCtD
Ciclesonide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000182	0.00108	CcSEcCtD
Ciclesonide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000181	0.00107	CcSEcCtD
Ciclesonide—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000181	0.00107	CcSEcCtD
Ciclesonide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00107	CcSEcCtD
Ciclesonide—Hypertension—Metformin—type 2 diabetes mellitus	0.00018	0.00107	CcSEcCtD
Ciclesonide—Urticaria—Glyburide—type 2 diabetes mellitus	0.00018	0.00107	CcSEcCtD
Ciclesonide—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00018	0.00107	CcSEcCtD
Ciclesonide—Back pain—Losartan—type 2 diabetes mellitus	0.000179	0.00106	CcSEcCtD
Ciclesonide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000179	0.00106	CcSEcCtD
Ciclesonide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00105	CcSEcCtD
Ciclesonide—Chest pain—Metformin—type 2 diabetes mellitus	0.000178	0.00105	CcSEcCtD
Ciclesonide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000177	0.00105	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000176	0.00104	CcSEcCtD
Ciclesonide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000175	0.00104	CcSEcCtD
Ciclesonide—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000175	0.0329	CrCbGaD
Ciclesonide—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000175	0.0329	CrCbGaD
Ciclesonide—Nausea—Glipizide—type 2 diabetes mellitus	0.000175	0.00104	CcSEcCtD
Ciclesonide—Rash—Glimepiride—type 2 diabetes mellitus	0.000173	0.00103	CcSEcCtD
Ciclesonide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000173	0.00103	CcSEcCtD
Ciclesonide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00102	CcSEcCtD
Ciclesonide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00102	CcSEcCtD
Ciclesonide—Headache—Glimepiride—type 2 diabetes mellitus	0.000172	0.00102	CcSEcCtD
Ciclesonide—Cough—Irbesartan—type 2 diabetes mellitus	0.000172	0.00102	CcSEcCtD
Ciclesonide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000172	0.00102	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00017	0.00101	CcSEcCtD
Ciclesonide—Alclometasone—NR3C1—type 2 diabetes mellitus	0.00017	0.032	CrCbGaD
Ciclesonide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.00017	0.00101	CcSEcCtD
Ciclesonide—Angioedema—Losartan—type 2 diabetes mellitus	0.000169	0.001	CcSEcCtD
Ciclesonide—Infection—Metformin—type 2 diabetes mellitus	0.000169	0.001	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000168	0.000997	CcSEcCtD
Ciclesonide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000168	0.000992	CcSEcCtD
Ciclesonide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000168	0.000992	CcSEcCtD
Ciclesonide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000167	0.000987	CcSEcCtD
Ciclesonide—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000166	0.0312	CrCbGaD
Ciclesonide—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000166	0.0312	CrCbGaD
Ciclesonide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000165	0.000976	CcSEcCtD
Ciclesonide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000165	0.000975	CcSEcCtD
Ciclesonide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000164	0.000974	CcSEcCtD
Ciclesonide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000971	CcSEcCtD
Ciclesonide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000164	0.000971	CcSEcCtD
Ciclesonide—Palpitations—Losartan—type 2 diabetes mellitus	0.000164	0.000969	CcSEcCtD
Ciclesonide—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000164	0.0308	CrCbGaD
Ciclesonide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000163	0.000967	CcSEcCtD
Ciclesonide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000163	0.000963	CcSEcCtD
Ciclesonide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000163	0.000963	CcSEcCtD
Ciclesonide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000163	0.000963	CcSEcCtD
Ciclesonide—Cough—Losartan—type 2 diabetes mellitus	0.000162	0.000957	CcSEcCtD
Ciclesonide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000162	0.000957	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000161	0.000956	CcSEcCtD
Ciclesonide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000161	0.000954	CcSEcCtD
Ciclesonide—Infection—Irbesartan—type 2 diabetes mellitus	0.00016	0.000945	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000159	0.000944	CcSEcCtD
Ciclesonide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000159	0.000943	CcSEcCtD
Ciclesonide—Chest pain—Losartan—type 2 diabetes mellitus	0.000158	0.000934	CcSEcCtD
Ciclesonide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000158	0.000934	CcSEcCtD
Ciclesonide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000926	CcSEcCtD
Ciclesonide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000156	0.000925	CcSEcCtD
Ciclesonide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000156	0.000921	CcSEcCtD
Ciclesonide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00092	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000155	0.000919	CcSEcCtD
Ciclesonide—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000154	0.029	CrCbGaD
Ciclesonide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000154	0.000913	CcSEcCtD
Ciclesonide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000152	0.000899	CcSEcCtD
Ciclesonide—Infection—Losartan—type 2 diabetes mellitus	0.00015	0.00089	CcSEcCtD
Ciclesonide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00015	0.000887	CcSEcCtD
Ciclesonide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000149	0.000879	CcSEcCtD
Ciclesonide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000872	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000147	0.00087	CcSEcCtD
Ciclesonide—Fatigue—Metformin—type 2 diabetes mellitus	0.000147	0.000869	CcSEcCtD
Ciclesonide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000147	0.000869	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000146	0.000867	CcSEcCtD
Ciclesonide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000146	0.000865	CcSEcCtD
Ciclesonide—Angioedema—Ramipril—type 2 diabetes mellitus	0.000145	0.00086	CcSEcCtD
Ciclesonide—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000145	0.0273	CrCbGaD
Ciclesonide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000143	0.000848	CcSEcCtD
Ciclesonide—Rash—Glyburide—type 2 diabetes mellitus	0.000143	0.000846	CcSEcCtD
Ciclesonide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000143	0.000845	CcSEcCtD
Ciclesonide—Headache—Glyburide—type 2 diabetes mellitus	0.000142	0.000841	CcSEcCtD
Ciclesonide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000141	0.000837	CcSEcCtD
Ciclesonide—Palpitations—Ramipril—type 2 diabetes mellitus	0.00014	0.000831	CcSEcCtD
Ciclesonide—Hydrocortisone—SHBG—type 2 diabetes mellitus	0.00014	0.0263	CrCbGaD
Ciclesonide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000139	0.000821	CcSEcCtD
Ciclesonide—Cough—Ramipril—type 2 diabetes mellitus	0.000139	0.000821	CcSEcCtD
Ciclesonide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000139	0.00082	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000138	0.000816	CcSEcCtD
Ciclesonide—Urticaria—Metformin—type 2 diabetes mellitus	0.000135	0.000801	CcSEcCtD
Ciclesonide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000135	0.000801	CcSEcCtD
Ciclesonide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000135	0.000801	CcSEcCtD
Ciclesonide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000135	0.000798	CcSEcCtD
Ciclesonide—Nausea—Glyburide—type 2 diabetes mellitus	0.000135	0.000797	CcSEcCtD
Ciclesonide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000135	0.000797	CcSEcCtD
Ciclesonide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000134	0.000794	CcSEcCtD
Ciclesonide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000133	0.000788	CcSEcCtD
Ciclesonide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000133	0.000785	CcSEcCtD
Ciclesonide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000132	0.000783	CcSEcCtD
Ciclesonide—Fatigue—Losartan—type 2 diabetes mellitus	0.00013	0.000772	CcSEcCtD
Ciclesonide—Rash—Gliclazide—type 2 diabetes mellitus	0.000128	0.00076	CcSEcCtD
Ciclesonide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000128	0.000759	CcSEcCtD
Ciclesonide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000128	0.000756	CcSEcCtD
Ciclesonide—Headache—Gliclazide—type 2 diabetes mellitus	0.000127	0.000755	CcSEcCtD
Ciclesonide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000124	0.000732	CcSEcCtD
Ciclesonide—Hydrocortamate—CYP3A4—type 2 diabetes mellitus	0.000123	0.0231	CrCbGaD
Ciclesonide—Dizziness—Orlistat—type 2 diabetes mellitus	0.000122	0.000723	CcSEcCtD
Ciclesonide—Asthenia—Metformin—type 2 diabetes mellitus	0.000122	0.000723	CcSEcCtD
Ciclesonide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000716	CcSEcCtD
Ciclesonide—Urticaria—Losartan—type 2 diabetes mellitus	0.00012	0.000711	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000118	0.000699	CcSEcCtD
Ciclesonide—Prednisone—NR3C1—type 2 diabetes mellitus	0.000118	0.0222	CrCbGaD
Ciclesonide—Rash—Valsartan—type 2 diabetes mellitus	0.000118	0.000698	CcSEcCtD
Ciclesonide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000118	0.000697	CcSEcCtD
Ciclesonide—Headache—Valsartan—type 2 diabetes mellitus	0.000117	0.000694	CcSEcCtD
Ciclesonide—Rash—Orlistat—type 2 diabetes mellitus	0.000116	0.00069	CcSEcCtD
Ciclesonide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000116	0.000689	CcSEcCtD
Ciclesonide—Headache—Orlistat—type 2 diabetes mellitus	0.000116	0.000685	CcSEcCtD
Ciclesonide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000116	0.000684	CcSEcCtD
Ciclesonide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000115	0.000683	CcSEcCtD
Ciclesonide—Budesonide—CYP3A4—type 2 diabetes mellitus	0.000114	0.0215	CrCbGaD
Ciclesonide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000114	0.000676	CcSEcCtD
Ciclesonide—Dizziness—Metformin—type 2 diabetes mellitus	0.000113	0.000667	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000663	CcSEcCtD
Ciclesonide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000112	0.000662	CcSEcCtD
Ciclesonide—Nausea—Valsartan—type 2 diabetes mellitus	0.000111	0.000658	CcSEcCtD
Ciclesonide—Nausea—Orlistat—type 2 diabetes mellitus	0.00011	0.00065	CcSEcCtD
Ciclesonide—Prednisolone—NR3C1—type 2 diabetes mellitus	0.000109	0.0205	CrCbGaD
Ciclesonide—Asthenia—Losartan—type 2 diabetes mellitus	0.000108	0.000642	CcSEcCtD
Ciclesonide—Rash—Metformin—type 2 diabetes mellitus	0.000107	0.000636	CcSEcCtD
Ciclesonide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000107	0.000635	CcSEcCtD
Ciclesonide—Headache—Metformin—type 2 diabetes mellitus	0.000107	0.000632	CcSEcCtD
Ciclesonide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000106	0.000629	CcSEcCtD
Ciclesonide—NR3C1—nerve—type 2 diabetes mellitus	0.000105	0.105	CbGeAlD
Ciclesonide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000103	0.00061	CcSEcCtD
Ciclesonide—Rash—Irbesartan—type 2 diabetes mellitus	0.000101	0.0006	CcSEcCtD
Ciclesonide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000101	0.000599	CcSEcCtD
Ciclesonide—Nausea—Metformin—type 2 diabetes mellitus	0.000101	0.000599	CcSEcCtD
Ciclesonide—Headache—Irbesartan—type 2 diabetes mellitus	0.000101	0.000596	CcSEcCtD
Ciclesonide—Dizziness—Losartan—type 2 diabetes mellitus	0.0001	0.000592	CcSEcCtD
Ciclesonide—Alclometasone—CYP3A4—type 2 diabetes mellitus	9.86e-05	0.0185	CrCbGaD
Ciclesonide—Flunisolide—CYP3A4—type 2 diabetes mellitus	9.6e-05	0.0181	CrCbGaD
Ciclesonide—Nausea—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000565	CcSEcCtD
Ciclesonide—Rash—Losartan—type 2 diabetes mellitus	9.53e-05	0.000565	CcSEcCtD
Ciclesonide—Dermatitis—Losartan—type 2 diabetes mellitus	9.53e-05	0.000564	CcSEcCtD
Ciclesonide—Paramethasone—CYP3A4—type 2 diabetes mellitus	9.48e-05	0.0178	CrCbGaD
Ciclesonide—Headache—Losartan—type 2 diabetes mellitus	9.47e-05	0.000561	CcSEcCtD
Ciclesonide—SERPINA6—nephron tubule—type 2 diabetes mellitus	9.38e-05	0.0934	CbGeAlD
Ciclesonide—Asthenia—Ramipril—type 2 diabetes mellitus	9.3e-05	0.000551	CcSEcCtD
Ciclesonide—Nausea—Losartan—type 2 diabetes mellitus	8.98e-05	0.000532	CcSEcCtD
Ciclesonide—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	8.94e-05	0.0168	CrCbGaD
Ciclesonide—Dizziness—Ramipril—type 2 diabetes mellitus	8.57e-05	0.000508	CcSEcCtD
Ciclesonide—CES1—cardiovascular system—type 2 diabetes mellitus	8.43e-05	0.084	CbGeAlD
Ciclesonide—Hydrocortisone—NR3C1—type 2 diabetes mellitus	8.32e-05	0.0156	CrCbGaD
Ciclesonide—SERPINA6—kidney—type 2 diabetes mellitus	8.24e-05	0.0821	CbGeAlD
Ciclesonide—Rash—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000484	CcSEcCtD
Ciclesonide—Dermatitis—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000484	CcSEcCtD
Ciclesonide—Headache—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000481	CcSEcCtD
Ciclesonide—SERPINA6—cortex of kidney—type 2 diabetes mellitus	8.03e-05	0.0799	CbGeAlD
Ciclesonide—Nausea—Ramipril—type 2 diabetes mellitus	7.7e-05	0.000456	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	7.7e-05	0.00139	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	7.6e-05	0.00137	CbGpPWpGaD
Ciclesonide—CES1—adipose tissue—type 2 diabetes mellitus	7.44e-05	0.074	CbGeAlD
Ciclesonide—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	7.41e-05	0.00133	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	7.31e-05	0.00132	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	7.17e-05	0.00129	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	7.11e-05	0.00128	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	6.97e-05	0.00125	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	6.95e-05	0.00125	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	6.94e-05	0.00125	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	6.93e-05	0.00125	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	6.93e-05	0.00125	CbGpPWpGaD
Ciclesonide—Prednisone—CYP3A4—type 2 diabetes mellitus	6.84e-05	0.0129	CrCbGaD
Ciclesonide—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	6.8e-05	0.00122	CbGpPWpGaD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—NFKB1—type 2 diabetes mellitus	6.8e-05	0.00122	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	6.71e-05	0.00121	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	6.7e-05	0.00121	CbGpPWpGaD
Ciclesonide—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	6.65e-05	0.0012	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	6.62e-05	0.00119	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	6.61e-05	0.00119	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	6.58e-05	0.00119	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	6.54e-05	0.00118	CbGpPWpGaD
Ciclesonide—Prednisolone—CYP3A4—type 2 diabetes mellitus	6.3e-05	0.0119	CrCbGaD
Ciclesonide—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	6.07e-05	0.00109	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	6.02e-05	0.00108	CbGpPWpGaD
Ciclesonide—Prednisone—ALB—type 2 diabetes mellitus	5.97e-05	0.0112	CrCbGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	5.92e-05	0.00107	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	5.85e-05	0.00105	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	5.81e-05	0.00105	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	5.73e-05	0.00103	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	5.66e-05	0.00102	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	5.62e-05	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	5.57e-05	0.001	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	5.53e-05	0.000995	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—MTR—type 2 diabetes mellitus	5.52e-05	0.000994	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	5.43e-05	0.000978	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	5.37e-05	0.000967	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP11A1—type 2 diabetes mellitus	5.35e-05	0.000963	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	5.34e-05	0.000961	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	5.27e-05	0.00095	CbGpPWpGaD
Ciclesonide—CES1—liver—type 2 diabetes mellitus	5.21e-05	0.0519	CbGeAlD
Ciclesonide—SERPINA6—liver—type 2 diabetes mellitus	5.21e-05	0.0519	CbGeAlD
Ciclesonide—NR3C1—islet of Langerhans—type 2 diabetes mellitus	5.1e-05	0.0508	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	4.98e-05	0.000897	CbGpPWpGaD
Ciclesonide—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	4.82e-05	0.00907	CrCbGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.41e-05	0.000795	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.36e-05	0.000786	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.35e-05	0.000784	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4.3e-05	0.000775	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	4.27e-05	0.00077	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP3A4—type 2 diabetes mellitus	4.25e-05	0.000766	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	4.2e-05	0.000756	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	4.16e-05	0.00075	CbGpPWpGaD
Ciclesonide—NR3C1—nephron tubule—type 2 diabetes mellitus	4.11e-05	0.0409	CbGeAlD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	3.74e-05	0.000673	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	3.7e-05	0.000667	CbGpPWpGaD
Ciclesonide—NR3C1—cardiovascular system—type 2 diabetes mellitus	3.69e-05	0.0367	CbGeAlD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	3.67e-05	0.000661	CbGpPWpGaD
Ciclesonide—NR3C1—kidney—type 2 diabetes mellitus	3.61e-05	0.0359	CbGeAlD
Ciclesonide—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	3.61e-05	0.00065	CbGpPWpGaD
Ciclesonide—NR3C1—pancreas—type 2 diabetes mellitus	3.59e-05	0.0357	CbGeAlD
Ciclesonide—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	3.52e-05	0.000634	CbGpPWpGaD
Ciclesonide—NR3C1—cortex of kidney—type 2 diabetes mellitus	3.52e-05	0.035	CbGeAlD
Ciclesonide—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	3.49e-05	0.000629	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	3.49e-05	0.000629	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	3.45e-05	0.000622	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	3.45e-05	0.000621	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	3.42e-05	0.000616	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	3.39e-05	0.00061	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	3.37e-05	0.000607	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.34e-05	0.000602	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.3e-05	0.000594	CbGpPWpGaD
Ciclesonide—NR3C1—adipose tissue—type 2 diabetes mellitus	3.25e-05	0.0324	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	3.18e-05	0.000573	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	3.17e-05	0.000571	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	3.15e-05	0.000566	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	2.88e-05	0.00052	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	2.85e-05	0.000514	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	2.85e-05	0.000512	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	2.81e-05	0.000507	CbGpPWpGaD
Ciclesonide—CYP3A4—kidney—type 2 diabetes mellitus	2.73e-05	0.0272	CbGeAlD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	2.72e-05	0.00049	CbGpPWpGaD
Ciclesonide—CYP2D6—kidney—type 2 diabetes mellitus	2.69e-05	0.0267	CbGeAlD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	2.62e-05	0.000471	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	2.55e-05	0.000459	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	2.54e-05	0.000457	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	2.4e-05	0.000432	CbGpPWpGaD
Ciclesonide—NR3C1—liver—type 2 diabetes mellitus	2.28e-05	0.0227	CbGeAlD
Ciclesonide—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	2.23e-05	0.000402	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	2.23e-05	0.000402	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.19e-05	0.000395	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.19e-05	0.000394	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.16e-05	0.000389	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.16e-05	0.000388	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	2.11e-05	0.000381	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	2.11e-05	0.000381	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.1e-05	0.000377	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.1e-05	0.000377	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.06e-05	0.000371	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	2.02e-05	0.000363	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	1.95e-05	0.000351	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	1.86e-05	0.000335	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	1.86e-05	0.000335	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	1.8e-05	0.000324	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	1.8e-05	0.000324	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	1.8e-05	0.000324	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	1.8e-05	0.000324	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.8e-05	0.000324	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	1.78e-05	0.000321	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	1.74e-05	0.000313	CbGpPWpGaD
Ciclesonide—CYP3A4—liver—type 2 diabetes mellitus	1.73e-05	0.0172	CbGeAlD
Ciclesonide—CYP2D6—liver—type 2 diabetes mellitus	1.7e-05	0.0169	CbGeAlD
Ciclesonide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.67e-05	0.0003	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	1.66e-05	0.000299	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	1.64e-05	0.000296	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	1.64e-05	0.000296	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	1.6e-05	0.000288	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	1.53e-05	0.000276	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	1.53e-05	0.000275	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	1.53e-05	0.000275	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	1.53e-05	0.000275	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.52e-05	0.000273	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	1.46e-05	0.000264	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	1.46e-05	0.000264	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.46e-05	0.000263	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.46e-05	0.000263	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	1.41e-05	0.000254	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	1.41e-05	0.000254	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	1.39e-05	0.000249	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.38e-05	0.000249	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.38e-05	0.000249	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	1.36e-05	0.000245	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	1.36e-05	0.000245	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	1.36e-05	0.000245	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.34e-05	0.000241	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.32e-05	0.000237	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.28e-05	0.000231	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.26e-05	0.000227	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.22e-05	0.000219	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.22e-05	0.000219	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.2e-05	0.000216	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.17e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.17e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.17e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.17e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.17e-05	0.000212	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.16e-05	0.000209	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.16e-05	0.000209	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.16e-05	0.000209	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.16e-05	0.000209	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.14e-05	0.000205	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.11e-05	0.0002	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.07e-05	0.000194	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.07e-05	0.000194	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.05e-05	0.000189	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.04e-05	0.000188	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.03e-05	0.000186	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.99e-06	0.00018	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.99e-06	0.00018	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.99e-06	0.00018	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	9.63e-06	0.000174	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	9.58e-06	0.000172	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	9.58e-06	0.000172	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	9.44e-06	0.00017	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	9.44e-06	0.00017	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	9.38e-06	0.000169	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	9.26e-06	0.000167	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	9.22e-06	0.000166	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	9.22e-06	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	9.2e-06	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	9.2e-06	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	9.2e-06	0.000166	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	9.14e-06	0.000165	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	9.06e-06	0.000163	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	8.98e-06	0.000162	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.9e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.9e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.9e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	8.87e-06	0.00016	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	8.37e-06	0.000151	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	8.25e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	8.25e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	8.25e-06	0.000149	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	8.1e-06	0.000146	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	8.03e-06	0.000145	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	7.85e-06	0.000141	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.84e-06	0.000141	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.57e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.57e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.57e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.57e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.55e-06	0.000136	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.46e-06	0.000134	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.46e-06	0.000134	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.28e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.26e-06	0.000131	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	7.15e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.15e-06	0.000129	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.75e-06	0.000122	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.3e-06	0.000113	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.17e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.17e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.17e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.17e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.14e-06	0.000111	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	6.06e-06	0.000109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	6.05e-06	0.000109	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	6.01e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	6.01e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	6.01e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.98e-06	0.000108	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.88e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.87e-06	0.000106	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.8e-06	0.000105	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.72e-06	0.000103	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.61e-06	0.000101	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.5e-06	9.9e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.48e-06	9.86e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.39e-06	9.72e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.39e-06	9.72e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.39e-06	9.72e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.33e-06	9.61e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.29e-06	9.54e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.27e-06	9.49e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.25e-06	9.45e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.14e-06	9.25e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	5.05e-06	9.1e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.96e-06	8.93e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.93e-06	8.89e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.88e-06	8.79e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.88e-06	8.79e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.8e-06	8.65e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.72e-06	8.5e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.71e-06	8.47e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.68e-06	8.42e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.68e-06	8.42e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.65e-06	8.38e-05	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	4.12e-06	7.41e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.1e-06	7.38e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.03e-06	7.26e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.03e-06	7.26e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	4.02e-06	7.24e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.01e-06	7.23e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.96e-06	7.13e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.84e-06	6.92e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.74e-06	6.73e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.69e-06	6.64e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.67e-06	6.61e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.59e-06	6.47e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.58e-06	6.45e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-06	6.35e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-06	6.35e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.49e-06	6.28e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.44e-06	6.2e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-06	5.95e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-06	5.84e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.22e-06	5.81e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.14e-06	5.65e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.09e-06	5.56e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.08e-06	5.54e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-06	5.48e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.68e-06	4.83e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.63e-06	4.73e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.41e-06	4.34e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	4.15e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	4.15e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.11e-06	3.8e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	2.92e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.91e-05	CbGpPWpGaD
